President Honors Kibbe for Vascular Disease Research

By

Jesse Brown VA Medical Center, and a member of the Institute for BioNanotechnology in Medicine at the Robert H. Lurie Medical Research Center. She is being revered for her innovative research in the field of nitric oxide vascular biology and the development of novel translational therapies for patients with vascular disease.

“Having my research recognized in this manner has been very rewarding not only for me, but also for all the members of my lab, past and present, as this achievement represents the hard work and dedication of a team of researchers and staff all working toward a common goal,” Kibbe says. “Without these individuals, as well as the support of my partners, my division chief, NMH and the VA, receiving an award like this would not be possible.”

The awards are coordinated by the White House Office of Science and Technology Policy within the Executive Office of the President. Kibbe and the other awardees were selected on the basis of two criteria: pursuit of innovative research at the frontiers of science and technology and a commitment to community service as demonstrated through scientific leadership, public education or community outreach.

Kibbe’s research explores how to extend the effectiveness of vascular procedures such as balloon angioplasty and stenting, bypass grafting and other vascular interventions with limited durability. The focus in the Kibbe Lab is to further the understanding of nitric oxide vascular biology in order to develop nitric oxide-based therapies to improve patient care.

“This award has provided greater exposure of my research and has opened the door for potential collaborations which will aid in its growth,” Kibbe says. “Meeting President Obama and the other awardees was an experience I will never forget!”